Perry Andrew
Insider CIK 1877793 · GTHX Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 32,100 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 67,050 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | U Tender | 2024-09-18 | 2024-09-18 | 14,232 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer | 2024-09-18 | 2024-09-18 | 114,482 | — | $0 | 14,232 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-09-18 | 2024-09-18 | 16,100 | — | $0 | 128,714 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-07-05 | 2024-07-08 | 1,337 | $2.51 | $3.4K | 112,614 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-07-01 | 2024-07-03 | 35,000 | — | $0 | 113,951 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-05-13 | 2024-05-15 | 8,151 | $4.79 | $39.0K | 78,951 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-08 | 67,050 | — | $0 | 67,050 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-01-03 | 2024-01-08 | 379 | $3.12 | $1.2K | 89,136 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-01-03 | 2024-01-08 | 2,034 | $3.12 | $6.3K | 87,102 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-08 | 33,570 | — | $0 | 89,515 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2023-07-05 | 2023-07-07 | 355 | $2.45 | $870 | 55,945 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-05-10 | 2023-05-12 | 35,000 | — | $0 | 56,300 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2023-01-04 | 2023-01-05 | 820 | $5.58 | $4.6K | 21,300 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 32,100 | — | $0 | 32,100 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-01-03 | 2023-01-05 | 16,100 | — | $0 | 22,120 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 26,500 | — | $0 | 26,500 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2022-01-03 | 2022-01-05 | 6,000 | — | $0 | 6,020 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2021-08-16 | 2021-08-17 | 300,000 | — | $0 | 300,000 | SEC↗ |